GVAG
CVS icon

Great Valley Advisor Group’s CVS Health CVS Stock Holding History

Great Valley Advisor Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
+2,935
New +$262K ﹤0.01% 850
2026
Q1 		– Sell
-5,558
Closed -$441K – 1008
2025
Q4 		$441K Buy
5,558
+262
+5% +$20.7K 0.01% 665
2025
Q3 		$399K Buy
5,296
+7
+0.1% +$480 0.01% 689
2025
Q2 		$365K Sell
5,289
-490
-8% -$32.1K 0.01% 690
2025
Q1 		$392K Buy
5,779
+605
+12% +$36.2K 0.01% 650
2024
Q4 		$232K Sell
5,174
-1,960
-27% -$110K 0.01% 774
2024
Q3 		$449K Sell
7,134
-3,597
-34% -$210K 0.01% 587
2024
Q2 		$634K Sell
10,731
-10,105
-48% -$632K 0.02% 480
2024
Q1 		$1.66M Buy
20,836
+1,793
+9% +$137K 0.05% 300
2023
Q4 		$1.5M Buy
19,043
+1,968
+12% +$140K 0.05% 282
2023
Q3 		$1.19M Sell
17,075
-1,183
-6% -$83.8K 0.05% 290
2023
Q2 		$1.26M Sell
18,258
-1,250
-6% -$88.9K 0.05% 285
2023
Q1 		$1.45M Buy
19,508
+780
+4% +$65.4K 0.07% 259
2022
Q4 		$1.74M Sell
18,728
-1,447
-7% -$140K 0.09% 235
2022
Q3 		$1.92M Sell
20,175
-399
-2% -$39.5K 0.11% 201
2022
Q2 		$1.91M Buy
20,574
+12,846
+166% +$1.25M 0.1% 201
2022
Q1 		$786K Sell
7,728
-757
-9% -$79.5K 0.05% 312
2021
Q4 		$837K Buy
8,485
+154
+2% +$14.2K 0.05% 288
2021
Q3 		$707K Buy
8,331
+362
+5% +$30.3K 0.05% 293
2021
Q2 		$649K Buy
7,969
+95
+1% +$7.78K 0.05% 293
2021
Q1 		$592K Sell
7,874
-632
-7% -$46K 0.06% 274
2020
Q4 		$581K Buy
8,506
+1,114
+15% +$72.5K 0.06% 258
2020
Q3 		$431K Buy
7,392
+248
+3% +$15.4K 0.05% 278
2020
Q2 		$465K Buy
7,144
+878
+14% +$55.3K 0.08% 245
2020
Q1 		$372K Sell
6,266
-19
-0.3% -$1.27K 0.1% 214
2019
Q4 		$467K Buy
6,285
+1,887
+43% +$132K 0.1% 212
2019
Q3 		$277K Sell
4,398
-63
-1% -$3.73K 0.07% 271
2019
Q2 		$242K Buy
4,461
+402
+10% +$21.6K 0.06% 287
2019
Q1 		$219K Buy
4,059
+390
+11% +$24.1K 0.07% 272
2018
Q4 		$240K Buy
+3,669
New +$274K 0.09% 201

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Great Valley Advisor Group's CVS Position: Q2 2026 in Review

Great Valley Advisor Group opened a new position in CVS Health (CVS) in Q2 2026: 2,935 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #850 among its holdings. This is a return to the name: Great Valley Advisor Group previously reported a position in CVS as recently as Q4 2025.

Great Valley Advisor Group first reported a position in CVS in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.92M in Q3 2022. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Great Valley Advisor Group held 2,935 shares of CVS Health worth $304K as of Q2 2026.
  • CVS Health was a new Great Valley Advisor Group position in Q2 2026.
  • CVS Health made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #850 holding.
  • Great Valley Advisor Group first reported a position in CVS Health in Q4 2018 and has held it in 30 quarters since.
  • Great Valley Advisor Group's CVS Health position peaked at $1.92M in Q3 2022.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.